HOME Top Market Reports Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

By: marketsandmarkets.com
Publishing Date: August 2017
Report Code: BT 5526

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global next-generation sequencing (NGS) services market is projected to reach USD 2,748.6 Million by 2022 from USD 868.1 Million in 2016, growing at a CAGR of 21.0% during 2017-2022.

Years considered for the study

Historical Year - 2015
Base Year – 2016
Estimated Year - 2017
Forecast Period – 2017 - 2022

Objectives of the study are:

  • To define, describe, and forecast the NGS services market by type, technology, application, end user, and region
  • To provide detailed information regarding factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges) along with current trends
  • To analyze micromarkets with respect to their growth trends, prospects, and contributions to the total market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World
  • To profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches; agreements, partnerships, and collaborations; mergers & acquisitions; and research & development activities in the NGS services market

Research Methodology

This research study involved the usage of extensive secondary sources; directories; and databases such as Hoovers, Bloomberg Business, Factiva, and Avention; along with government databases, to identify and collect information for this technology-based, market-oriented, and commercial study of the NGS services market. In-depth interviews were conducted with various primary respondents that included key industry participants, subject-matter experts (SMEs), D-level and C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects of the market.

The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various trade, business, and professional associations

Next-Generation Sequencing (NGS) Services Market

To know about the assumptions considered for the study, download the pdf brochure

BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN (Germany), Novogene Corporation (China), and GATC Biotech AG (Germany),are some of the key players in the global NGS services market. These players are striving to expand their presence in the emerging countries of Asia-Pacific and the Middle East regions through partnerships, agreements, and collaborations.

Stakeholders

  • NGS services companies
  • NGS services vendors and distributors
  • NGS data analysis companies
  • Research institutes and government organizations
  • Venture capitalists and other government funding organizations
  • Research and consulting firms
  • Healthcare institutions (hospitals and medical schools)
  • Pharmaceutical and biotechnology companies
  • Contract research organizations (CROs)

Scope of the Report

This research report categorizes the hybrid operating room market into the following segments and subsegments:

By Type

  • Targeted Sequencing/Gene Panels
  • RNA-Seq
  • De Novo Sequencing
  • Exome Sequencing
  • CHiP-Seq
  • Whole-genome Sequencing
  • Methyl-Seq
  • Other Services

By Technology

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-time (SMRT) Sequencing
  • Nanopore Sequencing

By Application

  • Diagnostics
    • Oncology
    • Reproductive Health
    • Infectious Diseases
    • Rare Genetic Disorders
    • Others
  • Drug Discovery
  • Biomarker Discovery
  • Microbial Genetics, Agriculture, and Animal Research
  • Other Applications (Marine Research, Research in Biofuels, Forensic Medicine, Food Safety, and Phylogeographic & Phylogenetic Studies)

By End User

  • Academic & Government Institutes and Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users (NPOs, Agrigenomics Organizations, and Consumer Genomic Companies)

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Service Analysis

  • Service matrix which gives a detailed comparison of the service portfolios of the top five companies in the NGS services market.

Geographical Analysis

  • Further breakdown of the RoW NGS services market into the Middle East, Latin America, and Africa

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Approach
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Data
                    2.2.2.1 Breakdown of Primaries
                    2.2.2.2 Key Data From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Next-Generation Sequencing (NGS) Services Market Overview
    4.2 Global NGS Services Market, By Type, 2015 vs 2017 vs 2022 (USD Million)
    4.3 Geographic Analysis: NGS Services Market, By Technology (2017)
    4.4 NGS Services Market, By Application
    4.5 Global NGS Services Market, By End User, 2017 vs 2022
    4.6 Geographical Snapshot of the NGS Services Market

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Declining Price of Sequencing
                    5.2.1.2 High Cost of Sequencing Infrastructure
                    5.2.1.3 Need for Skilled Professionals for Efficient NGS Sample Preparation and Analysis
                    5.2.1.4 Sequencing Services, the Preferred Option for NGS Applications With Low Throughput Requirements
                    5.2.1.5 Technological Advancements in the Field of Sequencing
           5.2.2 Restraints
                    5.2.2.1 Installation of In-House Sequencing Facilities in Hospitals and Universities
           5.2.3 Opportunities
                    5.2.3.1 Analysis of Complex Sequencing Data
                    5.2.3.2 Increasing Applications in Cancer and Agrigenomics Research
           5.2.4 Challenges
                    5.2.4.1 Accuracy & Standardization Concerns in Diagnostic Testing
                    5.2.4.2 Ethical Issues Related to NIPT

6 Global Next-Generation Sequencing Services Market, By Technology (Page No. - 42)
    6.1 Introduction
    6.2 Sequencing By Synthesis
    6.3 Ion Semiconductor Sequencing
    6.4 Single-Molecule Real-Time Sequencing
    6.5 Nanopore Sequencing

7 Global NGS Services Market, By Service Type (Page No. - 49)
    7.1 Introduction
    7.2 Targeted Resequencing & Custom Gene Panels
    7.3 RNA-Seq
    7.4 De Novo Sequencing
    7.5 Exome Sequencing
    7.6 Chip-Seq
    7.7 Whole-Genome Sequencing
    7.8 Methyl-Seq
    7.9 Other Services

8 Next-Generation Sequencing Services Market, By Application (Page No. - 59)
    8.1 Introduction
    8.2 Diagnostics
           8.2.1 Oncology
           8.2.2 Infectious Diseases
           8.2.3 Rare Genetic Disorders
           8.2.4 Reproductive Health
           8.2.5 Other Diagnostic Applications
    8.3 Drug Discovery
    8.4 Biomarker Discovery
    8.5 Agriculture & Animal Research
    8.6 Other Applications

9 Next-Generation Sequencing Services Market, By End User (Page No. - 72)
    9.1 Introduction
           9.1.1 Academic & Government Institutes and Research Centers
           9.1.2 Hospitals & Clinics
           9.1.3 Pharmaceutical & Biotechnology Companies
           9.1.4 Other End Users

10 Global Next-Generation Sequencing Services Market, By Region (Page No. - 78)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 105)
     11.1 Introduction
     11.2 Market Ranking Analysis
     11.3 Competitive Leadership Benchmarking
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Companies
     11.4 Strength of Product Portfolio (For 25 Players)
     11.5 Business Strategy Excellence (For 25 Players)

*Top 25 Companies Analyzed for This Study are - Illumina, Inc., BGI, Eurofins Scientific SE, Perkinelmer, Inc., Qiagen N.V., Gatc Biotech AG, Macrogen Inc., DNA Link, Inc, Genotypic Technology Pvt Ltd, Wuxi Apptec, Genewiz, Inc., Takara Bio Inc., Scigenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Genomics Limited, Oxford Gene Technology, Sysmex Corporation, Genomics Biosci & Tech. Co., Ltd., Zymo Research Corp, Source Bioscience, Integragen Sa, Centogene AG, Otogenetics Corporation, Novogene Corporation, Personalis, Inc.

12 Company Profiles (Page No. - 110)
     12.1 Introduction
(Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
     12.2 BGI
     12.3 Illumina, Inc.
     12.4 Perkinelmer, Inc.
     12.5 Eurofins Scientific SE
     12.6 Gatc Biotech AG
     12.7 Macrogen, Inc.
     12.8 Qiagen N.V.
     12.9 Genotypic Technology Pvt. Ltd.
     12.10 Genewiz, Inc.
     12.11 DNA Link, Inc.
     12.12 Takara Bio Inc. (Part of Takara Holding Company Inc.)
     12.13 Scigenom Labs Pvt. Ltd
     12.14 Novogene Corporation
     12.15 Personalis, Inc.
     12.16 LGC Limited (A Part of KKR & Co. L.P.)

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 147)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (56 Tables)

Table 1 NGS Services Market, By Region, 2015–2022 (USD Million)
Table 2 NGS Services Market for Sequencing By Synthesis, By Region, 2015–2022 (USD Million)
Table 3 NGS Services Market for Ion Semiconductor Sequencing, By Region, 2015–2022 (USD Million)
Table 4 NGS Services Market for Single-Molecule Real-Time Sequencing, By Region, 2015–2022 (USD Million)
Table 5 NGS Services Market for Nanopore Sequencing, By Region, 2015–2022 (USD Million)
Table 6 NGS Services Market, By Type, 2015–2022 (USD Million)
Table 7 Targeted Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 8 RNA-Seq Services Market, By Region, 2015–2022 (USD Million)
Table 9 De Novo Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 10 Exome Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 11 Chip-Seq Services Market, By Region, 2015–2022 (USD Million)
Table 12 Whole-Genome Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 13 Methyl-Seq Services Market, By Region, 2015–2022 (USD Million)
Table 14 Other NGS Services Market, By Region, 2015–2022 (USD Million)
Table 15 Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 16 NGS Diagnostic Services Market, By Application, 2015–2022 (USD Million)
Table 17 Next-Generation Sequencing Services Market for Diagnostic Applications, By Region, 2015–2022 (USD Million)
Table 18 Next-Generation Sequencing Services Market for Drug Discovery, By Region, 2015–2022 (USD Million)
Table 19 Next-Generation Sequencing Services Market for Biomarker Discovery, By Region, 2015–2022 (USD Million)
Table 20 Next-Generation Sequencing Services Market for Agriculture and Animal Research, By Region, 2015–2022 (USD Million)
Table 21 Next-Generation Sequencing Services Market for Other Applications, By Region, 2015–2022 (USD Million)
Table 22 Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)
Table 23 Next-Generation Sequencing Services Market for Academic & Government Institutes and Research Centers, By Region, 2015–2022 (USD Million)
Table 24 Next-Generation Sequencing Services Market for Hospitals & Clinics, By Region, 2015–2022 (USD Million)
Table 25 Next-Generation Sequencing Services Market for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 26 Next-Generation Sequencing Services Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 27 Next-Generation Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 28 North America: Next-Generation Sequencing Services Market, By Country, 2015–2022 (USD Million)
Table 29 North America: Next-Generation Sequencing Services Market, By Type, 2015–2022 (USD Million)
Table 30 North America: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 31 North America: Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 32 North America: Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)
Table 33 U.S.: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 34 Canada: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 35 Europe: Next-Generation Sequencing Services Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Next-Generation Sequencing Services Market, By Type, 2015–2022 (USD Million)
Table 37 Europe: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 38 Europe: Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 39 Europe: Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)
Table 40 Germany: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 41 U.K.: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 42 France: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 43 RoE: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 44 Asia-Pacific: Next-Generation Sequencing Services Market, By Country, 2015–2022 (USD Million)
Table 45 Asia-Pacific: Next-Generation Sequencing Services Market, By Type, 2015–2022 (USD Million)
Table 46 Asia-Pacific: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 47 Asia-Pacific: Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 48 Asia-Pacific: Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)
Table 49 China: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 50 Japan: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 51 India: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 52 RoAPAC: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 53 RoW: Next-Generation Sequencing Services Market, By Type, 2015–2022 (USD Million)
Table 54 RoW: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 55 RoW: Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 56 RoW: Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)


List of Figures (38 Figures)

Figure 1 Global NGS Services Market: Research Approach
Figure 2 Research Design
Figure 3 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 4 NGS Services Market: Bottom-Up Approach
Figure 5 NGS Services Market: Top-Down Approach
Figure 6 NGS Services Market: Data Triangulation
Figure 7 Next-Generation Sequencing Services Market, By Type, 2017 vs 2022
Figure 8 Next-Generation Sequencing Services Market, By Technology, 2017 vs 2022 (USD Million)
Figure 9 Next-Generation Sequencing Services Market, By Application, 2017 vs 2022 (USD Million)
Figure 10 Next-Generation Sequencing Services Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Geographical Snapshot of the Next-Generation Sequencing Services Market
Figure 12 Increasing Applications of NGS in Cancer and Agrigenomics Research to Offer Significant Growth Opportunities During the Forecast Period
Figure 13 North America to Dominate the NGS Services Market in 2017
Figure 14 Agriculture & Animal Research Segment to Register the Highest Growth Rate in the NGS Services Market Between 2017 & 2022
Figure 15 Academic & Government Institutes and Research Centers Segment Will Continue to Dominate the Global NGS Services Market in 2022
Figure 16 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 17 Next-Generation Sequencing Services Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Human Whole-Genome Sequencing Cost Estimated By the National Human Genome Research Institute
Figure 19 Nanopore Sequencing to Register the Highest Growth During the Forecast Period (2017 to 2022)
Figure 20 NGS Services Market, By Technology, 2015–2022 (USD Million)
Figure 21 Targeted Resequencing/Custom Gene Panels Segment Will Continue to Dominate the Global Next-Generation Sequencing Services Market in 2022
Figure 22 Diagnostics Segment Will Continue to Dominate the Global Next-Generation Sequencing Services Market in 2022
Figure 23 Growth in Number of Genetic Tests (2012–2016)
Figure 24 Increasing Publications Related to Biomarker Discovery Based on NGS During 2011-2016
Figure 25 Academic & Government Institutes and Research Centers to Register the Highest CAGR in the Forecast Period
Figure 26 Next-Generation Sequencing Services Market, By Region
Figure 27 North America: Next-Generation Sequencing Services Market Snapshot
Figure 28 Europe: Next-Generation Sequencing Services Market Snapshot
Figure 29 Asia-Pacific: Next-Generation Sequencing Services Market Snapshot
Figure 30 RoW: Next-Generation Sequencing Services Market Snapshot
Figure 31 BGI, Eurofins Scientific Se, and Macrogen Were the Leading Providers for NGS Services Worldwide in 2016
Figure 32 NGS Services Market (Global) Competitive Leadership Mapping, 2017
Figure 33 Illumina, Inc.: Company Snapshot (2016)
Figure 34 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 35 Eurofins Scientific Se: Company Snapshot (2016)
Figure 36 Macrogen, Inc.: Company Snapshot (2015)
Figure 37 Qiagen N.V.: Company Snapshot (2016)
Figure 38 Takara Bio Inc.: Company Snapshot (2016)

The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 Million by 2022 from USD 1,059.2 Million in 2017, growing at a CAGR of 21.0% during the forecast period. Factors such as technological advancements in the field of robot-assisted surgeries, increasing number of minimally-invasive surgeries, and growing patient preference for affordable & effective surgical treatments are driving the growth of this market.

The report analyzes the global NGS services market by type, technology, application, end user, and region. Based on type, the targeted resequencing & custom gene panels segment accounted for the largest share of the market; owing it to the advantages of targeted resequencing it offers over conventional methods and development of technologically advanced NGS products and services for targeted resequencing.

Sequencing by synthesis technology accounted for the largest market share owing to the introduction of technologically advanced SBS platforms in the market which allows more efficient sequencing and reduces the cost of sequencing. Based on applications, the NGS services market is segmented into diagnostics, drug discovery, biomarker discovery, agriculture & animal research, and other applications. The diagnostics segment is estimated to account for the largest share of the global NGS services market in 2017 owing to its growing number of target diseases across the globe and technological advancements to support a wider range of NGS-based applications.

This report covers the NGS services market value data across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global NGS services market in 2016, followed by Europe. The large share in the North American region is mainly attributed to the presence of leading NGS service providers in the region, declining cost of sequencing, rising awareness of NGS services, increasing number of NGS-based research & clinical applications in the region, high incidence of target diseases such as cancer, and the favorable reimbursement scenario in the region. The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the rapid growth in the genomic research and NGS based diagnostics in emerging Asia-Pacific countries such as China and India, which will support the adoption of NGS services.

Next-Generation Sequencing (NGS) Services Market

The installation of in-house sequencing facilities in hospitals and universities is the key factors restraining the growth of this market.

As of 2016, BGI (China) dominates the market through its wide range of technologically advanced and innovative NGS services. The company adopts the strategy of agreements and partnerships to maintain its leadership position in the market. Other prominent players in the market included Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), and GATC Biotech AG (Germany)  among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo